Abstract: The present invention relates to in vitro methods of assessing the susceptibility or responsiveness of a subject to the treatment with an epidermal growth factor receptor (EGFR) inhibitor/antagonist, wherein the subject has been diagnosed or suspected of suffering from inflammation-associated cancer. These methods comprise determining the level of expression of EGFR in myeloid cells in a sample from the subject, wherein an expression of EGFR in the myeloid cells is indicative of the subject being susceptible to the treatment with an EGFR inhibitor/antagonist.

Abstract: The present invention relates to heteroaromatic chalcone derivatives, particularly the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these compounds, and their medical use, including their use in the treatment or prevention of cancer and, in particular, in the treatment or prevention of hematologic malignancies.

Abstract: Disclosed is a vaccine comprising a fiber protein, selected from fiber-2 protein of Fowl Adenovirus C (FAdV-C), fiber-2 protein of Fowl Adenovirus A (FAdV-A), fiber protein of Fowl Adenovirus B, D and E (FAdV-B, FAdV-D and FAdV-E), or an immunogenic fragment thereof for use in preventing hepatitis-hydropericardium Syndrome (HHS) or inclusion body hepatitis (IBH) or Gizzard Erosion (GE) in birds, preferably in poultry, especially in broilers.

Abstract: Radically polymerizable dental material, which contains at least one sulphonic acid ester of Formula 1: in which A is H, CN, an aromatic, cycloaliphatic, linear or branched aliphatic C1-C30-hydrocarbon radical or a combination thereof; X is COO— or —CON(R1)— or is absent; B is an aromatic, cycloaliphatic, linear or branched aliphatic C1-C30-hydrocarbon radical, or a combination thereof; R1 is hydrogen or an aromatic, cycloaliphatic, linear or branched aliphatic C1-C10-hydrocarbon radical; m is an integer from 1 to 6, n is an integer from 1 to 6 and p is an integer from 1 to 6; wherein m and p cannot simultaneously be greater than 1. The compounds of Formula 1 are active as chain transfer agents in radical polymerization.

Abstract: Disclosed is a vaccine comprising fiber (2) protein of Fowl Adeno-virus C (FAdV-C) or an immunogenic fragment thereof for use in preventing hepatitis-hydropericardium Syndrome (HHS) in birds, preferably in poultry, especially in broilers.

Abstract: The present invention relates to a pharmaceutical composition comprising a cyclotide for use in immune suppression as well as to a method for immune suppression comprising the step of administering an effective amount of a pharmaceutical composition comprising such a cyclotide to a subject in need thereof. The present invention also relates to a pharmaceutical composition comprising a cyclotide for use in treating or preventing a disorder selected from the group consisting of (i) an autoimmune disorder; (ii) a hypersensitivity disorder; and (iii) a lymphocyte-mediated inflammation. Likewise, the present invention also relates to a method for treating or preventing a disorder selected from the group consisting of (i) an autoimmune disorder; (ii) a hypersensitivity disorder; and (iii) a lymphocyte-mediated inflammation.

Abstract: The present invention relates to a method for Magnetic Resonance Imaging to depict an object by an image having pixels representing volume element of the object. The method comprises: Immobilizing the object and acquiring a reference image at a first echo time immediately following an excitation, wherein said reference image is complex-valued, with a reference magnitude value and a reference phase value for each pixel; acquiring a target image of the object with said receiver coil at a pre-selected second echo time, wherein said target image is complex-valued, with a target magnitude value and a target phase value for each pixel; subtracting, pixel by pixel, the reference phase value from the target phase value to obtain a corrected phase value for each pixel; and obtaining said image from said target magnitude values and said corrected phase values.

Abstract: The invention relates to an isolated nucleic acid molecule comprising at least one promoter that is active in fungal cells of the trichoderma species, wherein a nucleic acid sequence encoding an N-acetylglucosamine-2-epimerase and/or an N-acetylneuraminic acid synthase is operatively bound to each promoter. The at least one promoter that is active in fungal cells is a constitutive promoter.

Abstract: The present invention relates to a cell culture model of vascular calcification, comprising a first type of cultured vascular smooth muscle cells and a second type of cultured vascular smooth muscle cells, wherein the first type and the second type of vascular smooth muscle cells originate from blood vessels having a different diameter, e.g., from the human aorta and from a human coronary artery, respectively. This model allows to generate and analyze vascular calcification processes, including early calcification processes, in an advantageously simple and cost-effective way and with high sensitivity. It can further be used to identify and examine compounds capable of halting, inhibiting or reversing such vascular calcification processes.

Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.

Abstract: The invention relates to the use of sulfonic acid esters of the following Formula 1 and/or Formula 2, individually or as a mixture of more than one thereof, as regulators in polymerization reactions of radically polymerizable, ethylenically unsaturated monomers: wherein A in each case independently is selected from H, CN, linear, branched or cyclic aliphatic or aromatic C1-C30 hydrocarbon residues; X in each case independently is —COO— or —CON(R1)—, wherein the binding to A occurs via O or N, or is absent if A is an aromatic hydrocarbon residue or CN; B in each case independently is selected from linear, branched or cyclic aliphatic or aromatic C1-C30 hydrocarbon residues; R1 in each case independently is selected from hydrogen and linear, branched or cyclic aliphatic or aromatic C1-C10 hydrocarbon residues, which are optionally substituted with one or more OH groups, wherein the aliphatic hydrocarbon residues are optionally interrupted by one or more oxygen atoms; and n in each case independently is an

Abstract: A roadway joint device for providing a drivable joint section between a road and an adjoining structure, particularly a bridge structure, includes at least one joint element placed on a sliding surface adjacent to the bridge structure. A longitudinal axis of the joint element is arranged substantially parallel to a plane of the roadway and a bridge end section of the bridge structure. Joint gaps with a specified gap width are arranged between the joint element and the adjoining bridge end section and/or an adjoining retaining device arranged at a distance to the bridge end section. The joint element is attached to at least one rod, the rod being arranged substantially in the direction of the longitudinal axis of the bridge structure, anchored at one rod end in the bridge structure and another rod end thereof in the retaining device.

Abstract: An optical diode (1) comprising an optical wave guide for guiding light, preferably of a light mode, with a vacuum wavelength ?0, wherein the optical wave guide has a wave guide core (2, 3, 14) with a first index of refraction (n1), and the wave guide core (2, 3, 14) is surrounded by at least one second optical medium which has at least one second index of refraction (n2), wherein n1>n2 applies, wherein the wave guide core (2, 3, 14) has at least in sections a smallest lateral dimension (7) which is a smallest dimension of a cross section (6) perpendicular to a propagation direction (5) of the light in the wave guide core (2, 3, 14), wherein the smallest lateral dimension (7) is greater than or equal to ?0/(5*n1) and less than or equal to 20*?0/n1, wherein the optical diode (1) additionally comprises at least one absorber element (10, 11, 15, 16) which is arranged in a near field, wherein the near field consists of the electromagnetic field of the light of the vacuum wavelength ?0 in the wave guide core (2

Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.

Abstract: The present application relates to a RNA molecule comprising a RNA-polymerase binding aptamer, wherein said RNA-polymerase binding aptamer has a length of 15 to 60 nt, wherein said RNA-Polymerase binding aptamer binds to a RNA-polymerase with a KD of 50 nM or lower. Furthermore, the application discloses a DNA molecule comprising a sequence encoding an RNA-polymerase binding aptamer of the invention, and a method of producing a protein or RNA of interest comprising providing a vector according to the invention, said vector comprising an expression, introducing said vector into a host cell, and culturing said host cell in culture medium under conditions inducing transcription from the promoter of the expression vector, and optionally recovering the protein of interest from the host cell or culture medium. Furthermore, the application pertains methods for in vitro transcription and expression employing the RNA-polymerase binding apatamers.

Abstract: A spindle arrangement for a machine tool, comprising a spindle for driving a tool and at least one actuator for exciting vibration of the tool, characterized in that the spindle arrangement is provided with a compensation device for at least partly compensating the inertia forces produced by the vibration excitation in the spindle region.

Abstract: Provided are methods for suppressing IgE and IgG-mediated allergic reactions through monoclonal antibody applications. More specifically, methods are herein provided for safe induction of rapid desensitization. Specific embodiments are herein provided for suppressing allergic reactions in a subject, including specific methods of providing a monoclonal antibody selected from the group consisting of anti-Fc?RIa and anti-Fc?RIIb / RIII; administering the antibody to a subject at a dose that is lower than the level required to induce shock; and administering sequentially escalating doses of the monoclonal antibody so as to induce rapid desensitization to an allergen, thereby suppressing allergic reaction in the subject.

Abstract: The invention discloses a method for producing a single bacterial strain culture of Histomonas meleagridis (H. meleagridis), the method being characterized by the following steps: (a) providing a xenic culture of H. meleagridis comprising H. meleagridis cells with a wild type bacterial flora, (b) treating the xenic culture with a mixture of antibiotics thereby killing the wild type bacterial flora, (c) centrifuging and washing the H. meleagridis cells, (d) controlling effectiveness of step (b), (e) resuspending the washed H. meleagridis cells, (f) adding one or more single bacterial strain (s) to the resuspended H. meleagridis cells, and (g) culturing the one or more single bacterial strain (s) with the resuspended H. meleagridis cells so as to obtain a single bacterial strain culture of H. meleagridis.

Abstract: A method and a device for processing a light-polymerizable material (5, 55) for building up an object (27) in layers, using a lithography based generative manufacture having a construction platform (12) for building up the object (27), a projecting exposure unit (10, 60) that can be controlled for locally selected exposing of a surface on the construction platform (12, 62) to an intensity pattern having a prescribed shape, and a control unit (11, 61) prepared for polymerizing overlapping layers (28) on the construction platform (12, 62) in successive exposure steps, each having a prescribed geometry, by controlling the projecting exposure unit (10, 60), in order to thus successively build up the object (27) in the desired shape, said shape resulting from the sequence of layer geometries.

Abstract: A heat storage system using sand as a solid heat storage medium has a fluidized bed heat exchanger (3) arranged between and separated from a storage tank (1) for cold sand and a storage tank (2) for hot sand by weirs (4, 5). The heat exchanger (3) is divided into a plurality of chambers (7) by weirs (6). The weirs (4, 5, 6) are arranged as a combination of overflow and underflow weirs. Fluidized sand is produced in the chambers (7) by a blower (14) positioned underneath the heat exchanger (3). Heat is transferred from a heat source to the sand fluidized and from the fluidized sand to a heat transport medium by transferring mechanisms (8, 9) in the chambers (7). The sand is redirected in a horizontal direction by horizontally acting blowers and/or installations (12) projecting into a respective chamber from a side.